Protect Pharmaceutical Corporation PRTT OTC

Other OTC • Industrials • Conglomerates • US • USD

SharesGrow Score

92/100

5/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Protect Pharmaceutical Corporation (PRTT) trades at a trailing P/E of 0.1. Trailing earnings yield is 2,000.00%.

Criteria proven by this page:

VALUE (100/100, Pass) — P/E is below market average (0.1); earnings yield beats bond yields (2,000.00%).
Trailing Earnings Yield 2,000.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 90/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score

92/100

SG Score

View full scorecard →

✓

VALUE

100/100

Price-to-Earnings & upside

Proven by this page

—

FUTURE

N/A

No coverage

✓

PAST

100/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

MOAT

54/100

→ Income

✓

GROWTH

100/100

→ Income

✓

INCOME

100/100

→ Income

Valuation Snapshot — PRTT

Valuation Multiples

P/E (TTM)0.1

Forward P/EN/A

PEG Ratio0.00

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.02

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.98

Book Value / Share$0.00

Revenue / Share$2.30

FCF / Share$0.00

Yields & Fair Value

Earnings Yield2,000.00%

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2014	$8.48	$0.00	$458.15K	-
2015	$-1.44	$0.00	$-635K	-
2016	$-0.04	$0.00	$-41.71K	-
2017	$-0.10	$0.00	$-123K	-
2019	$0.00	$0.00	$-1.87K	-
2020	$0.11	$5.94M	$5.81M	97.8%
2021	$0.36	$78.79M	$20.21M	25.6%
2022	$0.43	$81.8M	$22.44M	27.4%
2023	$0.80	$136.16M	$45.91M	33.7%
2024	$0.98	$132.26M	$56.33M	42.6%